Cargando…
“Suffocating” tumors by blocking adaptation to hypoxia: a new headway in melanoma immunotherapy
We recently reported that inhibiting Hypoxia-inducible Factor-1α (Hif1a) transcriptional activity improves melanoma immunotherapy by driving immune cells into the tumor microenvironment (TME). This Author’s View provides additional perspectives on how hypoxia inhibitors combined with immunotherapy c...
Autores principales: | Janji, Bassam, Chouaib, Salem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437449/ https://www.ncbi.nlm.nih.gov/pubmed/34527430 http://dx.doi.org/10.1080/2162402X.2021.1968611 |
Ejemplares similares
-
The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?
por: Janji, Bassam, et al.
Publicado: (2022) -
Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic target
por: Noman, Muhammad Zaeem, et al.
Publicado: (2018) -
Firing up the cold tumors by targeting Vps34
por: Janji, Bassam, et al.
Publicado: (2020) -
New strategies for melanoma immunotherapy: How to overcome immunosuppression in the tumor microenvironment
por: Umansky, Viktor
Publicado: (2012) -
A role for EMT in CD73 regulation in breast cancer
por: Hasmim, Meriem, et al.
Publicado: (2022)